Compounds > haloperidol

haloperidol and 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate

haloperidol has been researched along with 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McCann, DJ; Su, TP1
Bowen, WD; Torrence-Campbell, C1

Other Studies

2 other study(ies) available for haloperidol and 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate

ArticleYear
Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 257, Issue:2

    Topics: Animals; Binding Sites; Cell Membrane; Cholic Acids; Culture Techniques; Haloperidol; Liver; Male; Phenazocine; Rats; Rats, Inbred F344; Receptors, Opioid; Receptors, sigma; Tritium

1991
Differential solubilization of rat liver sigma 1 and sigma 2 receptors: retention of sigma 2 sites in particulate fractions.
    European journal of pharmacology, 1996, May-23, Volume: 304, Issue:1-3

    Topics: Animals; Binding, Competitive; Cell Fractionation; Cell Membrane; Cholic Acids; Detergents; Guanidines; Haloperidol; In Vitro Techniques; Liver; Male; Pentazocine; Phenazocine; Protein Binding; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, sigma; Solubility; Subcellular Fractions

1996